Gastrointestinal Stromal Tumors
Showing NaN - NaN of 9
Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)
Completed
- Gastrointestinal Stromal Tumors
- DCC-2618
- Placebo Oral Tablet
-
Scottsdale, Arizona
- +34 more
Nov 17, 2022
Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib
Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- +2 more
-
Scottsdale, Arizona
- +25 more
Apr 16, 2021
Gastrointestinal Stromal Tumors Trial in Ann Arbor, New York (Pembrolizumab, Epacadostat)
Completed
- Gastrointestinal Stromal Tumors
-
Ann Arbor, Michigan
- +1 more
Mar 18, 2021
Gastrointestinal Stromal Tumors Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo, Best supportive care)
Completed
- Gastrointestinal Stromal Tumors
- Regorafenib (Stivarga, BAY73-4506)
- +2 more
-
Scottsdale, Arizona
- +56 more
Jan 27, 2021
Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)
Completed
- Gastrointestinal Stromal Tumors
- Nilotinib
- Best Supportive Care (BSC) +/- imatinib or sunitinib
-
Los Angeles, California
- +34 more
Jun 5, 2012